Clinical Trial Update: Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating KB003 in adults with moderate-to-severe asthma inadequately controlled by corticosteroids has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• KB003

Snippet

Sponsor: Humanigen, Inc. | Conditions: Moderate-to-Severe Asthma | Phase 2 | Status: COMPLETED | Results posted: 2015-02-02